| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene affects the expression of FMO1 mRNA" | 26377693 |
| C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in decreased expression of FMO1 mRNA" | 19162173 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of FMO1 mRNA | 19933214 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FMO1 mRNA" | 21394737 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of FMO1 mRNA" | 19114083 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of FMO1 mRNA" | 16984957 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of FMO1 mRNA" | 21346803 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of FMO1 mRNA" | 21346803 |
| C012180 | 2-aminopyrimidine | 2-aminopyrimidine analog binds to FMO1 protein | 19317514 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of FMO1 mRNA" | 16984957 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of FMO1 mRNA" | 18648102 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of FMO1 mRNA" | 25380136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMO1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMO1 mRNA" | 27188386 |
| C026729 | 4-aminophenol | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-aminophenol | 20369854 |
| C043455 | 4-fluoroaniline | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-fluoroaniline | 20369854 |
| C081015 | 4-fluoro-N-methylaniline | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-aminophenol | 20369854 |
| C081015 | 4-fluoro-N-methylaniline | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-fluoroaniline | 20369854 |
| C081015 | 4-fluoro-N-methylaniline | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-fluoro-N-methylaniline metabolite | 20369854 |
| C081015 | 4-fluoro-N-methylaniline | [FMO1 protein co-treated with NADP] results in increased oxidation of 4-fluoro-N-methylaniline | 20369854 |
| C081015 | 4-fluoro-N-methylaniline | [[FMO1 protein co-treated with NADP] results in increased oxidation of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol | 20369854 |
| C081015 | 4-fluoro-N-methylaniline | [FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline | 20369854 |
| C081015 | 4-fluoro-N-methylaniline | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol | 20369854 |
| C081015 | 4-fluoro-N-methylaniline | Methimazole inhibits the reaction [[[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol] | 20369854 |
| C521334 | 5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate | 5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate affects the expression of FMO1 mRNA | 20932894 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMO1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMO1 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of FMO1 mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of FMO1 mRNA | 11264010 |
| D000082 | Acetaminophen | [Clofibrate co-treated with Acetaminophen] affects the expression of FMO1 mRNA | 17585979 |
| D000082 | Acetaminophen | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FMO1 mRNA] | 17585979 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of FMO1 mRNA | 17202762|1752207 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol results in increased expression of FMO1 mRNA | 16908007 |
| D000638 | Amiodarone | Amiodarone affects the expression of FMO1 mRNA | 19483382 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of FMO1 mRNA | 16483693 |
| D017636 | Asbestos, Amphibole | "Asbestos, Amphibole results in decreased expression of FMO1 protein" | 20855422 |
| D001205 | Ascorbic Acid | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of FMO1 mRNA | 17639512 |
| C030935 | benz(a)anthracene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA | 27858113 |
| D001553 | Benzbromarone | Benzbromarone affects the expression of FMO1 mRNA | 19483382 |
| C006703 | benzo(b)fluoranthene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA | 27858113 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in decreased expression of FMO1 mRNA | 26377693 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in decreased expression of FMO1 mRNA | 22258563 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of FMO1 mRNA | 17879257 |
| D001564 | Benzo(a)pyrene | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of FMO1 mRNA] | 22228805 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA | 27858113 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of FMO1 mRNA | 21569818 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of FMO1 mRNA | 19770486 |
| D001591 | Benzydamine | Benzydamine inhibits the reaction [FMO1 protein results in increased chemical synthesis of clozapine N-oxide] | 18809730 |
| D001591 | Benzydamine | FMO1 protein results in increased oxidation of Benzydamine | 21435388 |
| D004958 | Estradiol | Estradiol results in decreased expression of FMO1 mRNA | 14664709 |
| D004958 | Estradiol | Estradiol results in decreased expression of FMO1 protein | 12151634 |
| D004958 | Estradiol | Estradiol results in increased expression of FMO1 protein | 12151634 |
| D004958 | Estradiol | Estradiol results in decreased expression of FMO1 mRNA | 24894866 |
| D004958 | Estradiol | Estradiol results in decreased expression of FMO1 protein | 21966433 |
| D004958 | Estradiol | resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1] | 24894866 |
| D004958 | Estradiol | resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1 mRNA] | 24894866 |
| C095105 | bexarotene | bexarotene results in decreased expression of FMO1 mRNA | 16648578 |
| C006780 | bisphenol A | bisphenol A results in increased expression of FMO1 mRNA | 27685785 |
| C006780 | bisphenol A | bisphenol A affects the methylation of FMO1 promoter | 27334623 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of FMO1 mRNA | 25181051 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FMO1 mRNA | 28628672 |
| C016274 | bromoacetate | bromoacetate results in decreased expression of FMO1 mRNA | 19753638 |
| C032036 | bromobenzene | bromobenzene results in increased expression of FMO1 mRNA | 15056800 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of FMO1 mRNA | 12419474 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of FMO1 mRNA | 25993096 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of FMO1 mRNA | 27339419 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of FMO1 mRNA | 12734012|1596334 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of FMO1 mRNA | 17522070 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of FMO1 protein | 12629582 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of FMO1 mRNA | 17851650 |
| D002725 | Chloroform | Chloroform results in decreased expression of FMO1 mRNA | 17522070 |
| D002746 | Chlorpromazine | FMO1 protein results in increased oxidation of Chlorpromazine | 6439199 |
| C031180 | chrysene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA | 27858113 |
| D002994 | Clofibrate | [Clofibrate co-treated with Acetaminophen] affects the expression of FMO1 mRNA | 17585979 |
| D002994 | Clofibrate | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FMO1 mRNA] | 17585979 |
| D002994 | Clofibrate | Clofibrate affects the expression of FMO1 mRNA | 19483382 |
| D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FMO1 mRNA | 17602206 |
| D003024 | Clozapine | FMO1 protein results in increased metabolism of Clozapine | 18809730 |
| C079149 | clozapine N-oxide | Benzydamine inhibits the reaction [FMO1 protein results in increased chemical synthesis of clozapine N-oxide] | 18809730 |
| C079149 | clozapine N-oxide | FMO1 protein results in increased chemical synthesis of clozapine N-oxide | 18809730 |
| D003033 | Coal Tar | Coal Tar results in decreased expression of FMO1 mRNA | 27858113 |
| D009249 | NADP | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-aminophenol | 20369854 |
| D009249 | NADP | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-fluoroaniline | 20369854 |
| D009249 | NADP | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-fluoro-N-methylaniline metabolite | 20369854 |
| D009249 | NADP | [FMO1 protein co-treated with NADP] results in increased oxidation of 4-fluoro-N-methylaniline | 20369854 |
| D009249 | NADP | [[FMO1 protein co-treated with NADP] results in increased oxidation of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol | 20369854 |
| D009249 | NADP | [FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline | 20369854 |
| D009249 | NADP | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol | 20369854 |
| D009249 | NADP | Methimazole inhibits the reaction [[[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol] | 20369854 |
| D003300 | Copper | [Copper co-treated with Dietary Sucrose] results in decreased expression of FMO1 mRNA | 26033743 |
| D003345 | Corticosterone | Corticosterone results in increased expression of FMO1 mRNA | 15755911 |
| C030123 | coumarin | coumarin results in decreased expression of FMO1 mRNA | 18480146 |
| D003407 | Creosote | Creosote results in increased expression of FMO1 mRNA | 19389177 |
| D003471 | Cuprizone | Cuprizone results in increased expression of FMO1 mRNA | 26577399|2752363 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of FMO1 mRNA | 27989131 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of FMO1 mRNA | 19770486 |
| D003543 | Cysteamine | FMO1 protein results in increased metabolism of Cysteamine | 6439199 |
| D003561 | Cytarabine | Cytarabine results in decreased expression of FMO1 mRNA | 21198554 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FMO1 mRNA | 28628672 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO1 mRNA | 16054899 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of FMO1 mRNA | 22733784 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of FMO1 mRNA | 15102944 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of FMO1 mRNA | 21266533 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of FMO1 mRNA | 26924002 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of FMO1 mRNA | 18042831 |
| D019422 | Dietary Sucrose | [Copper co-treated with Dietary Sucrose] results in decreased expression of FMO1 mRNA | 26033743 |
| D019422 | Dietary Sucrose | Dietary Sucrose results in decreased expression of FMO1 mRNA | 26033743 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FMO1 mRNA | 17602206 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA | 18544905 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of FMO1 mRNA | 18544905 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FMO1 mRNA | 25374375 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of FMO1 promoter | 25374375 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of FMO1 mRNA | 28943392 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of FMO1 mRNA | 19638242 |
| D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA | 18253720 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of FMO1 mRNA | 16636312 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of FMO1 mRNA | 15171707 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of FMO1 mRNA | 17072980|2538013 |
| C024629 | dimethyl phthalate | dimethyl phthalate results in decreased expression of FMO1 mRNA | 26924002 |
| D004726 | Endosulfan | Endosulfan results in decreased expression of FMO1 mRNA | 22515965 |
| D004785 | Environmental Pollutants | Environmental Pollutants results in increased expression of FMO1 mRNA | 20064776 |
| D004918 | Erythromycin Estolate | Erythromycin Estolate results in decreased expression of FMO1 mRNA | 17522070 |
| D000431 | Ethanol | Ethanol results in increased expression of FMO1 mRNA | 19167417 |
| D000431 | Ethanol | Ethanol results in increased expression of FMO1 mRNA | 16946407 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of FMO1 mRNA | 17555576 |
| D005001 | Ethionine | Ethionine affects the expression of FMO1 mRNA | 19483382 |
| D015025 | Zearalenone | Zearalenone results in decreased expression of FMO1 mRNA | 25455459 |
| D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA | 18253720 |
| D005284 | Fenthion | FMO1 protein results in increased oxidation of Fenthion | 14976351 |
| D005485 | Flutamide | Flutamide results in decreased expression of FMO1 mRNA | 24136188 |
| D005620 | Freund's Adjuvant | Freund's Adjuvant results in decreased expression of FMO1 mRNA | 21149847 |
| D005897 | Glafenine | Glafenine results in decreased expression of FMO1 mRNA | 24136188 |
| C004312 | glycidol | glycidol results in decreased expression of FMO1 mRNA | 24915197 |
| C010974 | glyphosate | glyphosate results in decreased expression of FMO1 mRNA | 26302742 |
| D006534 | Heptachlor Epoxide | Heptachlor Epoxide results in decreased expression of FMO1 mRNA | 25270620 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of FMO1 mRNA | 12419474 |
| D007099 | Imipramine | FMO1 protein results in increased oxidation of Imipramine | 6439199 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FMO1 mRNA | 28628672 |
| D007306 | Insecticides | FMO1 gene SNP affects the susceptibility to Insecticides | 20056567 |
| D007306 | Insecticides | Insecticides results in increased mutagenesis of FMO1 gene | 20056567 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FMO1 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO1 mRNA | 16054899 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of FMO1 mRNA | 20003209 |
| C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA | 18544905 |
| C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of FMO1 mRNA | 18544905 |
| C099406 | L 742694 | L 742694 affects the expression of FMO1 mRNA | 15102944 |
| D008070 | Lipopolysaccharides | [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FMO1 mRNA | 22777745 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of FMO1 mRNA | 10462538 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of FMO1 protein | 10462538 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [Lipopolysaccharides results in decreased expression of FMO1 mRNA] | 10462538 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [Lipopolysaccharides results in decreased expression of FMO1 protein] | 10462538 |
| C030272 | maleic acid | maleic acid results in increased expression of FMO1 mRNA | 28392987 |
| D008713 | Methimazole | FMO1 protein results in increased oxidation of Methimazole | 14976351 |
| D008713 | Methimazole | Methimazole inhibits the reaction [[[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol] | 20369854 |
| D008713 | Methimazole | FMO1 protein results in increased metabolism of Methimazole | 6439199 |
| D008714 | Methiocarb | FMO1 protein results in increased metabolism of Methiocarb | 27665777 |
| D008714 | Methiocarb | [FMO1 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide | 27665777 |
| C097911 | methiocarb sulfoxide | FMO1 protein results in increased abundance of methiocarb sulfoxide | 27665777 |
| C097911 | methiocarb sulfoxide | [FMO1 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide | 27665777 |
| C544071 | methyl 4-tolylsulfide | FMO1 protein results in increased oxidation of methyl 4-tolylsulfide | 19429252 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of FMO1 mRNA | 23179753 |
| D016686 | Monocrotaline | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA | 21224054 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of FMO1 mRNA | 26924002 |
| C500085 | muraglitazar | muraglitazar results in decreased expression of FMO1 mRNA | 21515302 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of FMO1 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of FMO1 mRNA" | 25554681 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in decreased expression of FMO1 mRNA | 15913567 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in decreased expression of FMO1 mRNA | 17522070|2538013 |
| C498045 | NCX 4040 | NCX 4040 results in increased expression of FMO1 mRNA | 20188076 |
| D019829 | Nevirapine | Nevirapine metabolite results in decreased expression of FMO1 mRNA | 23947594 |
| D009532 | Nickel | Nickel results in decreased expression of FMO1 mRNA | 24768652|2558310 |
| D009532 | Nickel | Nickel results in increased expression of FMO1 mRNA | 24084258 |
| C028007 | nickel monoxide | nickel monoxide results in decreased expression of FMO1 mRNA | 19167457 |
| C012655 | nimesulide | nimesulide results in decreased expression of FMO1 mRNA | 24136188 |
| D005996 | Nitroglycerin | Nitroglycerin results in decreased expression of FMO1 mRNA | 12102619 |
| C014112 | N-methyl-4-aminophenol | [[FMO1 protein co-treated with NADP] results in increased oxidation of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol | 20369854 |
| C014112 | N-methyl-4-aminophenol | [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol | 20369854 |
| C014112 | N-methyl-4-aminophenol | Methimazole inhibits the reaction [[[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol] | 20369854 |
| C015157 | N,N-dimethylaniline | "FMO1 protein results in increased metabolism of N,N-dimethylaniline" | 6439199 |
| D009853 | Omeprazole | Omeprazole affects the expression of FMO1 mRNA | 19483382 |
| D009966 | Orphenadrine | Orphenadrine affects the expression of FMO1 mRNA | 23665939 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of FMO1 mRNA | 25729387 |
| C030110 | oxaliplatin | oxaliplatin results in increased expression of FMO1 mRNA | 25729387 |
| D010098 | Oxycodone | Oxycodone affects the expression of FMO1 mRNA | 20487198 |
| D010098 | Oxycodone | Oxycodone results in increased expression of FMO1 mRNA | 23439660 |
| D010126 | Ozone | Ozone results in decreased expression of FMO1 mRNA | 12763052 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of FMO1 mRNA | 18042831 |
| D010396 | Penicillamine | Penicillamine results in increased expression of FMO1 mRNA | 22843330 |
| D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of FMO1 mRNA | 23892564 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of FMO1 mRNA | 19162173 |
| D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FMO1 mRNA] | 19482888 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of FMO1 mRNA | 19482888 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FMO1 mRNA | 25374375 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of FMO1 promoter | 25374375 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of FMO1 mRNA | 19162173 |
| D010672 | Phenytoin | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA | 21224054 |
| D010695 | Phlorhizin | Phlorhizin results in decreased expression of FMO1 mRNA | 22538082 |
| D010705 | Phosgene | Phosgene affects the expression of FMO1 mRNA | 16300373 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Lipopolysaccharides results in decreased expression of FMO1 mRNA] | 10462538 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Lipopolysaccharides results in decreased expression of FMO1 protein] | 10462538 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in decreased expression of FMO1 mRNA | 22484513 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of FMO1 mRNA | 25270620 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of FMO1 mRNA | 15375163|1742611 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of FMO1 mRNA | 19483382 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of FMO1 mRNA | 19162173 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of FMO1 mRNA | 27413110|2890350 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of FMO1 mRNA | 19162173 |
| D011374 | Progesterone | Progesterone results in increased expression of FMO1 mRNA | 23012394 |
| D011441 | Propylthiouracil | Propylthiouracil affects the expression of FMO1 mRNA | 19483382 |
| D054328 | Proton Pump Inhibitors | Proton Pump Inhibitors results in decreased expression of FMO1 mRNA | 25626140 |
| C010423 | pyrithione zinc | pyrithione zinc results in increased expression of FMO1 mRNA | 21424779 |
| D011794 | Quercetin | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of FMO1 mRNA | 17639512 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1] | 24894866 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1 mRNA] | 24894866 |
| D012293 | Rifampin | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA | 21224054 |
| C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO1 mRNA | 16054899 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of FMO1 mRNA | 21515302 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of FMO1 mRNA | 22155349 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of FMO1 mRNA | 25993096 |
| C016104 | sodium bichromate | sodium bichromate results in increased expression of FMO1 mRNA | 12325037 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased expression of FMO1 mRNA | 11719702 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased expression of FMO1 mRNA | 19429252 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased expression of FMO1 protein | 19429252 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of FMO1 mRNA | 17555576 |
| C501413 | tesaglitazar | tesaglitazar results in decreased expression of FMO1 mRNA | 21515302 |
| D013739 | Testosterone | Testosterone results in decreased expression of FMO1 mRNA | 20600201|2166921 |
| D013739 | Testosterone | Testosterone results in decreased expression of FMO1 protein | 12151634 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in decreased expression of FMO1 mRNA | 25172293 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of FMO1 mRNA | 21570461|2637764 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of FMO1 mRNA | 16214954 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in increased expression of FMO1 mRNA | 25975270 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FMO1 mRNA | 19933214|2892240 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of FMO1 mRNA | 18765683|1879615 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of FMO1 mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FMO1 mRNA | 11752688|1605489 |
| D013752 | Tetracycline | Tetracycline results in decreased expression of FMO1 mRNA | 17522070 |
| D013853 | Thioacetamide | [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of FMO1 mRNA | 28943392 |
| D013853 | Thioacetamide | Thioacetamide affects the expression of FMO1 mRNA | 19483382 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of FMO1 mRNA | 23557971 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of FMO1 mRNA | 25729387 |
| D019772 | Topotecan | Topotecan results in increased expression of FMO1 mRNA | 25729387 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMO1 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of FMO1 mRNA | 24935251|2627250 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of FMO1 mRNA | 19042947 |
| C057693 | troglitazone | troglitazone results in decreased expression of FMO1 mRNA | 19631733 |
| C057693 | troglitazone | troglitazone results in increased expression of FMO1 mRNA | 19631733 |
| C057693 | troglitazone | troglitazone results in decreased expression of FMO1 mRNA | 21515302 |
| D014415 | Tunicamycin | Tunicamycin results in decreased expression of FMO1 mRNA | 17127020 |
| C073339 | usnic acid | [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FMO1 mRNA | 22777745 |
| C406224 | valdecoxib | valdecoxib results in decreased expression of FMO1 mRNA | 24136188 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMO1 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of FMO1 mRNA | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of FMO1 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of FMO1 mRNA | 17963808 |
| C025643 | vinclozolin | vinclozolin affects the expression of FMO1 mRNA | 19015723 |
| C025643 | vinclozolin | vinclozolin results in increased expression of FMO1 mRNA | 22570695 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of FMO1 mRNA | 26682919 |
| D014800 | Vitallium | Vitallium analog results in increased expression of FMO1 mRNA | 23825117 |